Debut Plus

₹5.97

▼ -0.12 -1.97%

As of 22 Oct 2026 · delayed

NSE Listed · Healthcare

Vivimed Labs Limited (VIVIMEDLAB)

Volume: 12,10652W Range:₹4.75₹29.4
Market Cap₹49 Cr
Current Price₹5.97
Previous Close₹6.09
High / Low (52w)₹29.4 / ₹4.75
Volume12,106
Avg Vol (1W)—
Avg Vol (1M)—
Stock P/E—
Book Value₹-25.39
Dividend Yield0%
ROE—
ROA-12.85%
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹-21.13
P/B-0.24
Debt / Equity—
50 DMA₹6.14
200 DMA₹6.48
Day change-1.97%
Price Chart
₹6.21▲ 25.45% · 1Y
₹25₹519.2L
2025-10-27
2026-10-22

20-day avg volume: 84K shares

Cons
  • Revenue fell 40% YoY.
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025
Revenue₹12 Cr₹16 Cr₹21 Cr₹21 Cr₹26 Cr
EBITDA₹-135 Cr₹-11 Cr₹-1 Cr₹0 Cr₹2 Cr
Net Profit₹-147 Cr₹-17 Cr₹-7 Cr₹-5 Cr₹-6 Cr
EPS-17.74-2-0.88-0.66-0.68
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹70 Cr₹116 Cr₹149 Cr₹187 Cr—
EBITDA₹-146 Cr₹-9 Cr₹-25 Cr₹-187 Cr—
Net Profit₹-176 Cr₹-32 Cr₹-45 Cr₹-329 Cr—
EPS—-3.85-5.48-39.62-8.16
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹753 Cr₹921 Cr₹951 Cr₹995 Cr—
Total Liabilities₹964 Cr₹956 Cr₹956 Cr₹956 Cr—
Equity₹-211 Cr₹-35 Cr₹-5 Cr₹39 Cr—
Total Debt₹397 Cr₹376 Cr₹379 Cr₹381 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹8 Cr₹-1 Cr₹-24 Cr₹35 Cr—
Investing₹-1 Cr₹-5 Cr₹28 Cr₹-5 Cr—
Financing₹-6 Cr₹4 Cr₹-6 Cr₹-34 Cr—
Free Cash Flow₹7 Cr₹-6 Cr₹-26 Cr₹30 Cr—
Shareholding
Promoter 14.92% Institutions 9.37% Public 75.71%
About Vivimed Labs Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

www.vivimedlabs.com ↗
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search